📰 Ann Intern News
Page 5 - Ann Intern News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ann Intern. Real-time updates on events, politics, business and more.
May 24, 2023
Comprehensive in-hospital planning, postdischarge follow-up, ongoing support are key.
May 23, 2023
Survivors of firearm injury face poor physical health-related quality-of-life across time and worsened mental health for at least 6 months, according to researchers.In the United States, firearm injury is a public health crisis, Sydney C. Timmer-Murillo, PhD, a postdoctoral fellow in health and trauma psychology at the Medical College of Wisconsin, and colleagues wrote in Annals of Internal
May 17, 2023
Little is known about opioid prescribing patterns in patients with chronic overlapping pain conditions. This study suggests target populations for interventions to manage chronic pain.
May 6, 2023
Study aims to determine whether CEM improves breast cancer detection for women with dense breasts
May 3, 2023
In another sign of changing attitudes to pandemic policy, infectious disease specialists writing in the Annals of Internal ...
April 25, 2023
To provide equitable care, more states in the US are offering coverage for outpatient hemodialysis for undocumented immigrants.
April 18, 2023
Researchers who studied the impact of adherence to key health metrics on longevity have published findings that reinforce the value of lifestyle behaviors and health factors. The study, “Cardiovascular Health and Life Expectancy Among Adults in the United States,” was published April 10 in the American Heart Association (AHA) journal Circulation.
April 12, 2023
A new pilot study assessing the shelf life of insulin when stored at room temperature during the summer in India suggests most insulins maintained 95% potency or greater at 4 months relative to refrigerated insulin.
April 11, 2023
Leveraging data from more than 40,000 Veterans with primary hyperparathyroidism, a new NIA-funded study details the impact of parathyroidectomy on long-term kidney function among these patients.
March 7, 2023
PXL065 Phase 2 trial for the treatment of NASH met its primary efficacy endpoint for liver fat content reduction at 36-weeks for all doses. Fibrosis improvement by 1 stage without worsening